Dublin, 21 July 2020 (GLOBE NEWSWIRE) – The “market position for diagnosing infectious diseases through products and solutions (consumables, system, software and centres), generation (immunodiagnostic, PCR, INAAT), disease (HIV, HAIS, influenza), End user (hospital, reference los angelesboratory, studies) – The Global Forecast for 2027 report “has been added to the ResearchAndMarkets.com it will provide. This market position study on infectious disease diagnostics presents the old market position knowledge charge (2018 and 2019), current estimated knowledge (2020) and forecasts for 2027, through product and solution, generation, disease type and end user. The study also assesses industrial competition and analyses market position at the regional and national levels. After extensive secondary and number one studies and a comprehensive study of the market position scenario, the report presents a comprehensive study of key control factors, limitations and challenges. Opportunities The expansion of the infectious disease diagnostic market position is a great friend attributed to the growing global prevalence of infectious diseases such as COVID-19, Ebolos angels and swine flu, among others; Increased awareness of early detection through explicit diagnostic checks Increased investment for infectious disease diagnostic studies; and shifting the focus from centralized labs in Los Angeles to decentralized control centers at the point of service. In addition, advances in genomics and proteomics and emerging countries are providing expanding expansion opportunities for plos angelesyers in the infectious disease diagnostics market.
Based on products & solutions, the consumables segment is estimated to hold the largest share of the overall infectious disease diagnostics market in 2020. The large share of this segment is mainly attributed to the increasing prevalence of infectious diseases, rising awareness among the population to identify the diseases, and increasing use of kits and reagents to identify the organism causing various diseases in lesser time and cost.On the basis of technology, the immunodiagnostics segment is estimated to account for the largest share of the overall infectious disease diagnostics market in 2020. Increasing use of immunoassays in infectious disease testing, development of novel tests, rising trend of automation, increasing awareness about the health and fitness, and reduced complications associated with the instruments are some of the major factors driving the growth of this market.On the basis of disease type, the hepatitis diseases segment is estimated to hold the largest share of the overall infectious disease diagnostics market in 2020. Increasing number of blood transfusions and donations, increasing prevalence of hepatitis B & C infections, rising susceptibility of the geriatric population, growing awareness among the population, and benefits offered by point of care instruments & kits are expected to propel the growth of this segment.An in-depth analysis of the geographical scenario of the infectious disease diagnostics market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America region is estimated to command the largest share of the global infectious disease diagnostics market in 2020, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. However, Asia Pacific region is slated to register the highest growth during the forecast period primarily due to the rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage growing burden of infectious diseases, and government efforts to improve the accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.The key players operating in the global infectious disease diagnostics market are Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMrieux S.A. (France), Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience Inc. (U.S.), and Quidel Corporation (U.S.) among others.
Key topics covered:
1. Introduction
For additional information in this report, visit https://www.researchandmarkets.com/r/9os7uv
Reseek and Markets also provides a custom search that refers to a specific, comprehensive, and custom search feed.